127 related articles for article (PubMed ID: 3474819)
1. Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
Heinonen PK; Kallioniemi OP; Koivula T
Tumori; 1987 Jun; 73(3):301-2. PubMed ID: 3474819
[TBL] [Abstract][Full Text] [Related]
2. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
Ward BG; Cruickshank DJ; Tucker DF; Love S
Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
[TBL] [Abstract][Full Text] [Related]
3. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U
Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151
[TBL] [Abstract][Full Text] [Related]
4. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.
Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K
Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181
[TBL] [Abstract][Full Text] [Related]
5. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum alkaline phosphatase may enable early diagnosis of ovarian cancer.
Ben-Arie A; Hagay Z; Ben-Hur H; Open M; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):69-71. PubMed ID: 10471145
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
8. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum.
De Broe ME; Pollet DE
Clin Chem; 1988 Oct; 34(10):1995-9. PubMed ID: 3168210
[TBL] [Abstract][Full Text] [Related]
10. Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases.
Eerdekens MW; Nouwen EJ; Pollet DE; Briers TW; De Broe ME
Clin Chem; 1985 May; 31(5):687-90. PubMed ID: 3857128
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
[TBL] [Abstract][Full Text] [Related]
12. Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.
Harmenberg U; Frödin JE; Ljungdahl-Stähle E; Mellstedt H; Wahren B; Stigbrand T
Tumour Biol; 1989; 10(5):225-31. PubMed ID: 2814231
[TBL] [Abstract][Full Text] [Related]
13. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
[TBL] [Abstract][Full Text] [Related]
14. Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer.
Fisken J; Leonard RC; Shaw G; Bowman A; Roulston JE
J Clin Pathol; 1989 Jan; 42(1):40-5. PubMed ID: 2921344
[TBL] [Abstract][Full Text] [Related]
15. Placental serum alkaline phosphatase, defined by monoclonal antibody C2, in non-malignant diseases and in non-germinal tumors.
Fernández Llana B; Fernández Fernández M; Fernández Raigoso P; Alvarez A; Allende MT; Ruibal A
Int J Biol Markers; 1993; 8(4):246-8. PubMed ID: 8138665
[No Abstract] [Full Text] [Related]
16. Maternal serum placental alkaline phosphatase level and risk for preterm delivery.
Meyer RE; Thompson SJ; Addy CL; Garrison CZ; Best RG
Am J Obstet Gynecol; 1995 Jul; 173(1):181-6. PubMed ID: 7631677
[TBL] [Abstract][Full Text] [Related]
17. [Detection of placental alkaline phosphatase in ovarian cancer].
Wang R; Song L; Ding L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):107-9. PubMed ID: 8758806
[TBL] [Abstract][Full Text] [Related]
18. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
[TBL] [Abstract][Full Text] [Related]
19. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay.
Nozawa S; Udagawa Y; Ohkura H; Negishi Y; Akiya K; Inaba N; Takamizawa H; Kimura E; Terashima Y
Clin Chim Acta; 1990 Jan; 186(2):275-84. PubMed ID: 2178810
[TBL] [Abstract][Full Text] [Related]
20. Catalytic and immunologic activities of placental-like alkaline phosphatase in clinical studies. The value of PLAP in follow-up of ovarian cancer.
Haije WG; van Driel J; van der Burg ME
Clin Chim Acta; 1987 Jun; 165(2-3):165-75. PubMed ID: 2443278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]